15 Sep 2022

Company introduction

PDF 5.9 MB

Five production bases,GMP-Certified Manufacturer of APIs,With FDA, CEP, WHO etc

China Resource Double-Crane Pharmaceutical Co., Ltd API Division has 5 production bases in total. At present, it has about 1300 employees, of which 200 is for R&D. It covers an area of about 600,000 square meters, has more than 50 products, has sales and registrations in more than 30 countries and regions, and has a relatively complete API research, production and marketing integration capability. 

Strong products: Varsaltan,Allopurinol,Isoniazid, Pregabalin,Nicotinamide, Bendazole Hydrochloride, Amlodipine Besylate,Terazosin HCL, Sulfamethazine,

Olmesartan Medoxomil,Azilsartan,Pitavastatin Calcium, Sodium Nitroprusside,Triamterenum.

Content provided by our supplier

China Resource Double-crane Pharmaceutical CO., Ltd

  • CN
  • 2022
    On CPHI since
  • 5
  • 5000+
Company types
Generics/Biosimilars Manufacturer
Primary activities
API Producer

Other Content from China Resource Double-crane Pharmaceutical CO., Ltd ()